We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 967

Supreme Court of Canada denies leave to appeal in class action sought against manufacturers of children's cough and cold medicine

  • Davis LLP
  • -
  • Canada
  • -
  • September 5 2014

Ms. Wakelam sought to bring a class proceeding on behalf of all residents in British Columbia who purchased over-the-counter children's cough

A rare decertification decision from the BCCA stands: no leave to appeal Wakelam

  • McCarthy Tétrault LLP
  • -
  • Canada
  • -
  • September 5 2014

The Supreme Court of Canada yesterday refused the plaintiff's application for leave to appeal the British Columbia Court of Appeal's decertification

Délai de traitement des plaintes des usagers d’établissements de santé : la Cour d’appel confirme que le délai de 45 jours n’est pas impératif

  • Lavery de Billy LLP
  • -
  • Canada
  • -
  • September 4 2014

Dans un arrêt unanime du 4 septembre 20141, la Cour d’appel confirme que le délai de 45 jours prévu par la Loi sur les services de santé et les

Food, dietary supplement & cosmetics regulatory update, Issue 11

  • Jones Day
  • -
  • Canada, China, USA
  • -
  • August 8 2014

Last week, a divided federal appeals court ruled that FDA cannot be forced to ban antibiotics in food-producing healthy livestock. Thedecision comes

Plaintiff’s right to videorecord independent medical examinations andor to have a nominee present

  • Field Law
  • -
  • Canada
  • -
  • February 21 2013

The plaintiff sued for personal injury as a result of a motor vehicle accident that occurred on 14 November, 2007. The plaintiff alleged injuries to

Teva v Pfizer, or the “Viagra saga”: if there is no quid proper disclosure there can be no quo exclusive monopoly rights

  • Fasken Martineau DuMoulin LLP
  • -
  • Canada
  • -
  • November 19 2012

Sildenafil is the active ingredient in Viagra, the blockbuster potency-enhancing drug marketed by Pfizer

Markush claims can pose a risk of patent invalidity

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • June 28 2011

As patent law in Canada continues to evolve in significant ways, it is important to remind ourselves of cases from the past few years that continue to impact patent drafting today and to influence the validity of patents, especially pharmaceutical patents in Canada

Tax Court of Canada releases decision regarding medical expenses claimed for a surrogacy arrangement

  • Thorsteinssons LLP
  • -
  • Canada
  • -
  • August 14 2014

In Warnock v. The Queen, 2014 TCC 240, the Tax Court of Canada considered medical expense tax credits claimed by the taxpayer for various expenses

Federal court dismisses notion that patents should be given only one interpretation for all purposes

  • McCarthy Tétrault LLP
  • -
  • Canada
  • -
  • June 19 2014

In a pair of simultaneously released decisions on June 13, 2014, Justice O'Reilly allowed Allergan's applications (the "Applications") prohibiting

Methods of medical treatment and dosage claims

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • June 28 2011

In Canada, claims to methods of medical treatment are considered to fall outside the definition of invention according to section 2 of the Patent Act and a decision of the Supreme Court of Canada